Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...s, health shops and agro-veterinary shops; provide for the registration and regulation of medicines and allied substances; provide for the regulation of the manufacture, importation, exportation, possession, storage, distribution, supply, promotion, advertising, sale and use of medicines and allied substances; provide for the regulation and control of clinical trials; repeal and replace the Pharmaceutical Act, 2004; and provide for matters connected with, or incidental to, the foregoing.
more
A report submitted to the International Labour Organization, Geneva
To understand the mental health treatment gap in the Region of the Americas by examining the prevalence of mental health disorders, use of mental health services, and the global burden of disease.
Guidelines for adults on how to communicate with adolescents about mental health problems and other sensitive topics
Accessed: 31.03.2019
Alcohol misuses
Substance use disorders
Chapter G.1
Section I
Somatoform disorders
Child Psychiatry and Pediatrics
Chapter I.1
Psychiatrie de l'enfant
Chapitre B.1
Edition en français
Traduction : Apolline Morville
Sous la direction de : Priscille Gérardin
Avec le soutien de la SFPEADA
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.